Franklin Genomic Advancements ETF Rating $35.43 -0.20 (-0.56%) As of 05/29/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Franklin Genomic Advancements ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.HELX Aggregate RatingModerate Buy 2.78Holdings in HELX have an aggregate rating of Moderate Buy based on 389 analyst ratings issued in the past year covering 21 companies (65.7% of the portfolio).HELX Aggregate Price Target$35.43High Prediction$35.43Average Prediction$35.43Low Prediction$35.43Holdings in HELX have an aggregate price target of $35.43 and a range of $35.43 to $35.43 covering 21 companies (65.7% of the portfolio).HELX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy20 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Franklin Genomic Advancements ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 21 HELX Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.12%GHGuardant Health$129.69-2.6%1.6971 of 5 stars2.86$129.79 0.1%21Analyst ForecastInsider Trade6.50%NTRANatera$223.37+4.4%3.9832 of 5 stars2.79$256.60 14.9%19Trending NewsInsider Trade6.10%KRYSKrystal Biotech$309.03-0.4%2.9659 of 5 stars2.83$324.11 4.9%12Insider Trade4.51%UTHRUnited Therapeutics$556.82-0.9%3.933 of 5 stars2.85$619.42 11.2%13Trending NewsInsider Trade3.77%BBIOBridgeBio Pharma$66.26-3.2%3.4974 of 5 stars2.84$88.90 34.2%25Analyst DowngradeInsider Trade3.73%LGNDLigand Pharmaceuticals$231.96-1.2%3.4871 of 5 stars2.88$257.71 11.1%8Positive News3.01%INSMInsmed$106.91-1.3%3.7989 of 5 stars2.96$210.95 97.3%25Positive News2.96%VRTXVertex Pharmaceuticals$447.54-0.1%4.5395 of 5 stars2.88$555.91 24.2%25Positive NewsAnalyst Forecast2.90%ADPTAdaptive Biotechnologies$15.15-0.3%3.4329 of 5 stars2.63$19.57 29.2%8Positive News2.77%LLYEli Lilly and Company$1,105.37-1.9%4.5245 of 5 stars2.87$1,227.00 11.0%30Trending NewsAnalyst ForecastOptions Volume2.65%CTVACorteva$78.41-2.7%3.452 of 5 stars2.61$88.67 13.1%23Analyst Forecast2.29%ALNYAlnylam Pharmaceuticals$301.98-1.0%4.4581 of 5 stars2.85$463.13 53.4%26Positive NewsHigh Trading Volume2.23%REGNRegeneron Pharmaceuticals$614.78-1.1%4.9241 of 5 stars2.70$792.65 28.9%27Trending NewsHigh Trading Volume2.18%TVTXTravere Therapeutics$47.18-1.2%1.4325 of 5 stars2.69$47.83 1.4%132.10%MEDPMedpace$447.11-0.2%2.2836 of 5 stars2.20$467.08 4.5%15Trending News2.04%IONSIonis Pharmaceuticals$76.50-1.1%3.2885 of 5 stars2.90$100.90 31.9%21Positive NewsAnalyst Forecast2.00%NBIXNeurocrine Biosciences$158.30+1.2%4.3675 of 5 stars2.83$186.05 17.5%23Analyst ForecastInsider Trade1.82%BNTXBioNTech$95.95+2.7%3.1593 of 5 stars2.74$129.56 35.0%19Analyst Upgrade1.80%TEMTempus AI$50.47-1.6%3.0385 of 5 stars2.50$68.64 36.0%14Trending NewsInsider TradeOptions VolumeGap Up1.69%TWSTTwist Bioscience$66.87-3.1%1.3936 of 5 stars2.75$58.00 -13.3%8Positive News1.54%PTCTPTC Therapeutics$73.85+3.9%3.4427 of 5 stars2.64$89.00 20.5%14Positive NewsAnalyst Upgrade This page (BATS:HELX) was last updated on 5/30/2026 by MarketBeat.com Staff. From Our PartnersCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredSkip the Line Opportunity: The SpaceX IPOFormer tech executive and angel investor Jeff Brown - who identified Bitcoin, Tesla, and Nvidia before their h...Brownstone Research | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredTrump’s New Dollar revealedThe last time something like this happened was 1974 - a secret deal that quietly determined the financial fate...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Franklin Genomic Advancements ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Franklin Genomic Advancements ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HELX Stock Alerts